Updated May 24, 2026 · 2187 articles

Insights

Research, news and field guides on institutional positioning. Powered by real SEC filings — 13F, 13D/G, Form 4.

May 24, 2026
May 24Learn

Constructivist vs Aggressive Activism

Some activists collaborate with management; others wage public proxy fights. Here's the spectrum from constructivist to aggressive activism and why the style matters.

Marcus Chen
May 24Learn

Key-Person Risk: When a Fund Is One Person

Many tracked funds depend on a single star manager. Here's why key-person risk matters when you follow a fund's 13F — and how a leadership change can show up in the data.

Sarah Mitchell
May 24Learn

A Fund's First 13F: Why New Filers Are Worth Watching

Every quarter, funds cross the $100M threshold and file a 13F for the first time, revealing a once-private book in full. Here's how to read a debut filing.

Sarah Mitchell
May 24Learn

Survivorship Bias: The Trap in Following Famous Funds

Tracking only legendary investors hides the many who used the same strategies and failed. Here's how survivorship bias distorts 13F analysis — and how to avoid it.

Sarah Mitchell
May 24Learn

Style Drift: When a 13F Stops Matching the Mandate

A value fund full of growth stocks? A small-cap manager holding megacaps? That's style drift. Here's how to spot it in a 13F and why it matters.

Sarah Mitchell
May 24Learn

Pod Shops: Reading a Multi-Manager Platform's 13F

Millennium and Citadel run hundreds of independent pods, and their 13Fs aggregate them all. Here's why a pod shop's filing rarely reflects a single view.

Marcus Chen
May 24Learn

Crossover Funds: The Public-Private 13F

Crossover funds like Coatue invest before and after IPOs — but their 13F shows only the public half. Here's how to read a crossover fund's filing.

Sarah Mitchell
May 24Research

Maverick Q1 2026: A Tiger Cub Rotates Beyond Semis

Lee Ainslie's Maverick trimmed semiconductors and added Nu Holdings +92%, Boston Scientific +76%, plus new RTX and Argan in Q1 2026 — a Tiger cub broadening its growth book.

Marcus Chen
May 24Research

ValueAct Q1 2026: A Constructivist Activist's 18 Stocks

ValueAct's constructivist-activist book holds just 18 names — Visa, Amazon, Salesforce, BlackRock, Meta lead — concentrated stakes it engages over years.

Marcus Chen
May 24Learn

Founder-Led Companies: Why Investors Seek Them

Many long-term investors favor founder-led companies for their alignment and long-term mindset. Here's why the theme recurs in 13Fs — and the governance risks.

Sarah Mitchell
May 24Learn

Insurance Float: Why Insurers Hold Big Stock Portfolios

Insurers like Berkshire run huge equity 13Fs thanks to float — premiums they invest before paying claims. Here's how float works and why it makes insurers great investors.

Sarah Mitchell
May 24Learn

Pension Funds as 13F Filers: How to Read Them

CalPERS and state retirement systems file 13Fs too — but their books are largely indexed and externally managed. Here's how to read a pension fund's filing.

Sarah Mitchell
May 24Learn

Capital Allocation and Buybacks: Reading How Firms Use Cash

How management spends a company's cash — reinvesting, acquiring, or buying back stock — can make or break an investment. Here's why it shapes quality 13F portfolios.

Sarah Mitchell
May 24Learn

Total Return Swaps: The Exposure a 13F Can't See

A fund can have huge exposure to a stock that never appears in any 13F — through total return swaps. Here's how they work and why they're a disclosure blind spot.

Marcus Chen
May 24Learn

Return on Invested Capital: The Quality Metric

ROIC measures how well a company turns capital into profit, and it's the number quality investors care about most. Here's why ROIC drives so many 13F portfolios.

Sarah Mitchell
May 24Learn

What Is an Economic Moat? A Quality-Investing Guide

A moat is the durable competitive advantage that lets a company defend its profits for years. Here are the types of moats and how to spot a moat-driven 13F.

Sarah Mitchell
May 24Research

Southeastern Q1 2026: Longleaf's Deep-Value Adds

Southeastern's Longleaf book added aggressively to out-of-favor value names in Q1 2026 — Rayonier +90%, Fortune Brands +83%, Mattel +49% — far from the megacap crowd.

Marcus Chen
May 24Research

Trian Q1 2026: Peltz's 8-Stock Activist Book

Nelson Peltz's Trian holds just 8 positions, with 86% in Janus Henderson, GE Aerospace, and Solventum — activism expressed through extreme concentration.

Marcus Chen
May 24Research

Akre Q1 2026: Trimming Its Quality Compounders

Akre Capital's concentrated compounder book — Mastercard, Moody's, Visa, Roper — shrank 32.7% in Q1 2026 amid heavy trims, with FICO and Roper the exceptions.

Marcus Chen
May 24Learn

How an Activist Campaign Works

Filing a 13D is only the opening move. Here's the activist playbook — from quietly building a stake to proxy fights — and how it shapes reading an activist's holdings.

Marcus Chen
← PreviousPage 10 of 110Next →